Jae‐Yong Kwak

Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study

S.-E. Lee, Soo Young Choi, Ho Young Song et al. · Haematologica · 2016 · 165 citations · Full text

Nursing, Pharmacotherapy, Molecular Oncology +14

Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)

Seok Jin Kim, Chul Won Choi, Yeung‐Chul Mun et al. · BMC Cancer · 2011 · 131 citations · Full text

Medicine, Oncology, Pathology +12

SIRT1 Expression is Associated With Poor Prognosis of Diffuse Large B-Cell Lymphoma

Kyu Yun Jang, Sung Ho Hwang, Keun Sang Kwon et al. · The American Journal of Surgical Pathology · 2008 · 125 citations

Medicine, Oncology, Pathology +17

Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis

Na‐Ri Lee, Eun‐Kee Song, Kyu Yun Jang et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 105 citations

Life Sciences, Oncology, Pathology +17

Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma

Yok‐Lam Kwong, Sung Joon Kim, Eric Tse et al. · Annals of Oncology · 2017 · 83 citations · Full text

Medicine, Oncology, Chemotherapy +14